META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia
META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia
Not yet recruiting · NCT07689604 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia | Hemic and Lymphatic Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, hematologic disorder, hemolytic anemia, immune system disorder | Not yet recruiting | Early phase 1 | 2026-09-21 | NCT07689604 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hangzhou Leman Biotech Co., Ltd | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Blood Diseases Hospital, Chinese Academy of Medical Sciences | Tianjin | China | 1 |